AHK-CU

AHK-Cu is a synthetic tripeptide-copper complex consisting of the amino acid sequence Alanyl-Histidyl-Lysine (AHK) chelated to a copper(II) ion. It is structurally analogous to GHK-Cu — the most extensively studied copper peptide complex in biochemistry — with a single amino acid substitution: alanine replaces glycine at the N-terminal position of the tripeptide sequence. This modification alters the compound’s steric profile and copper chelation geometry, producing distinct pharmacokinetic and receptor interaction characteristics that make AHK-Cu both an independent research compound and a valuable comparative tool for researchers studying structure-activity relationships within the copper peptide class.

The structural difference between AHK-Cu and GHK-Cu is a single amino acid substitution at the N-terminus — alanine in place of glycine. While this may appear minor, the addition of alanine’s methyl side chain introduces steric bulk at the N-terminal position that alters the compound’s three-dimensional geometry, copper chelation angle, and interaction profile with biological targets. Research examining structure-activity relationships in copper peptide complexes has used this precise structural distinction to isolate which biological effects are attributable to the copper ion, which are sequence-dependent, and which are modified by N-terminal substitution. AHK-Cu is therefore not merely a variant of GHK-Cu but a distinct research compound with its own documented activity profile.

Published research has examined AHK-Cu’s effects on fibroblast activity and collagen synthesis in laboratory models, with studies documenting its capacity to stimulate collagen type I and type III production in dermal fibroblast cell lines. Research has compared AHK-Cu’s collagen-stimulating activity to GHK-Cu in controlled laboratory settings, with findings suggesting that the alanine substitution produces a compound with comparable or in some assays enhanced fibroblast stimulation relative to the parent compound. These findings have positioned AHK-Cu as a research compound of significant interest in dermatological and wound healing biology research.

AHK-Cu research has examined its pro-angiogenic properties in laboratory models, specifically its interaction with VEGF signaling pathways and its effects on endothelial cell migration and proliferation. Studies have documented AHK-Cu’s capacity to upregulate VEGF expression in fibroblast and endothelial cell models, with researchers noting its effects on capillary tube formation in in vitro angiogenesis assays. This pro-angiogenic activity is considered mechanistically complementary to its collagen-stimulating effects, as adequate vascularization is a prerequisite for effective tissue remodeling in research models.

The copper(II) ion is not merely a structural component of AHK-Cu — it is an active participant in the compound’s documented biological activity. Copper is an essential cofactor for lysyl oxidase, the enzyme responsible for crosslinking collagen and elastin fibers in the extracellular matrix. It is also required for the activity of superoxide dismutase, a critical antioxidant enzyme. Research on copper peptide complexes has established that the chelation of copper to a peptide carrier dramatically enhances its cellular uptake and bioavailability compared to free copper ions, while simultaneously activating biological pathways that the peptide alone does not engage. The copper component of AHK-Cu is therefore central to — not incidental to — its research applications.

Like GHK-Cu, AHK-Cu presents as a blue to blue-green lyophilized powder — a direct physical consequence of the copper(II) ion complex. Copper(II) ions absorb light in the orange-red spectrum, producing the characteristic blue appearance observed in copper-containing compounds. This color is a defining physical characteristic of the compound and confirms the presence of the copper complex. A white or colorless powder would indicate absence of the copper ion and should be treated as a quality concern.

AHK-Cu is primarily investigated in dermatological research, wound healing biology, vascular research, and extracellular matrix modeling. Its structural relationship to GHK-Cu makes it a particularly valuable tool for structure-activity relationship studies within the copper peptide class — research that requires precise structural analogs to isolate the contribution of individual molecular features to observed biological effects.

Every batch is independently tested for purity and identity prior to shipping. Full COA data including purity percentage and testing methodology is available via our batch lookup tool using your batch number.

AHK-Cu arrives as a blue to blue-green lyophilized powder in a sterile sealed vial — the blue color confirms the presence of the copper(II) ion complex. Pharmaceutical-grade mannitol is included as a lyoprotectant. This is expected and normal.

Lyophilized (unprepared) vials:
Refrigerated storage between 35.6–46.4°F (2–8°C) is recommended for AHK-Cu to maintain compound integrity. Like GHK-Cu, the copper complex makes refrigeration the preferred storage condition even for short-term storage. Avoid repeated temperature cycling as it accelerates degradation regardless of storage temperature.

Once prepared for laboratory use, refrigerated storage is standard protocol. Research and stability studies indicate that prepared peptide solutions of this class typically maintain peak integrity for approximately 28 to 40 days under refrigerated conditions. Beyond this window researchers should account for potential degradation when designing experimental protocols.

For laboratory research purposes only. Not for human consumption. Research use only.